Exciva is a Biotech company based in Heidelberg, Germany. It has raised $59M in total funding. Latest round: Series B.
Exciva funding overview
Exciva is a Biotech company based in Heidelberg, Germany. Exciva has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2026. The round record for Exciva runs through 2026; nothing later has been disclosed. Investors on record include Gimv, EQT Life Sciences, Fountain Healthcare Partners, LifeArc Ventures, Carma Fund, Modi Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Exciva has raised $59M in total disclosed funding across the rounds on record.
Who has invested in Exciva?
Gimv, EQT Life Sciences, Fountain Healthcare Partners, LifeArc Ventures, Carma Fund, Modi Ventures are named among the investors backing Exciva.
What was the latest Exciva funding round?
The most recent disclosed round is a Series B, announced in January 2026.
Where is Exciva based?
Exciva is based in Heidelberg, Germany.
What sector does Exciva operate in?
Exciva is tracked under Biotech from Heidelberg, Germany, with $59M in disclosed funding.
When did Exciva last raise?
The last disclosed Exciva round closed in January 2026 at Series B.
Exciva totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Heidelberg below to benchmark round size and investor mix.
